Nurix Therapeutics (NRIX) Interest & Investment Income (2019 - 2025)
Historic Interest & Investment Income for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $4.9 million.
- Nurix Therapeutics' Interest & Investment Income fell 2030.74% to $4.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $22.0 million, marking a year-over-year increase of 1135.95%. This contributed to the annual value of $22.0 million for FY2025, which is 1135.95% up from last year.
- Nurix Therapeutics' Interest & Investment Income amounted to $4.9 million in Q4 2025, which was down 2030.74% from $5.0 million recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Interest & Investment Income ranged from a high of $6.5 million in Q1 2025 and a low of $39000.0 during Q3 2021
- Its 5-year average for Interest & Investment Income is $2.9 million, with a median of $2.8 million in 2023.
- Per our database at Business Quant, Nurix Therapeutics' Interest & Investment Income crashed by 9422.22% in 2021 and then surged by 248717.95% in 2022.
- Quarter analysis of 5 years shows Nurix Therapeutics' Interest & Investment Income stood at $295000.0 in 2021, then soared by 568.81% to $2.0 million in 2022, then surged by 71.21% to $3.4 million in 2023, then surged by 81.05% to $6.1 million in 2024, then dropped by 20.31% to $4.9 million in 2025.
- Its last three reported values are $4.9 million in Q4 2025, $5.0 million for Q3 2025, and $5.6 million during Q2 2025.